Got­tlieb tes­ti­fies on sta­tus of FDA op­er­a­tions af­ter gov­ern­ment shut­down

FDA Com­mis­sion­er Scott Got­tlieb tes­ti­fied be­fore the House Com­mit­tee on Ap­pro­pri­a­tions Wednes­day on the cur­rent state of agency ac­tiv­i­ties. Got­tlieb ex­pressed con­fi­dence that the agency is “back on track,” de­spite the 35-day lapse in FDA ap­pro­pri­a­tions dur­ing the longest par­tial gov­ern­ment shut­down in US his­to­ry.

Mem­bers of the sub­com­mit­tee on agri­cul­ture, rur­al de­vel­op­ment, FDA and re­lat­ed agen­cies ques­tioned Got­tlieb on the sta­tus of the agency’s op­er­a­tions, par­tic­u­lar­ly re­gard­ing ef­forts to mit­i­gate the im­pact of the gov­ern­ment shut­down. They point­ed to FDA’s in­spec­tion­al work of med­ical prod­uct man­u­fac­tur­ing fa­cil­i­ties and re­serve of in­dus­try user fees as ar­eas of con­cern.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER